67 related articles for article (PubMed ID: 27981554)
1. Clinical significance of changes of expression of the Wnt/β-catenin signaling pathway in renal clear cell carcinoma.
Liu Z; Liu XW; Liu SA; Lv JJ; Fu Q
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4840-4845. PubMed ID: 27981554
[TBL] [Abstract][Full Text] [Related]
2. LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway.
Zhu L; Liu XL; Fu ZQ; Qiu P; Feng T; Yan B; Wei JL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2313-2320. PubMed ID: 32196582
[TBL] [Abstract][Full Text] [Related]
3. Expression of beta-catenin in renal cell carcinoma.
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
[TBL] [Abstract][Full Text] [Related]
5. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.
Gnemmi V; Bouillez A; Gaudelot K; Hémon B; Ringot B; Pottier N; Glowacki F; Villers A; Vindrieux D; Cauffiez C; Van Seuningen I; Bernard D; Leroy X; Aubert S; Perrais M
Cancer Lett; 2014 May; 346(2):225-36. PubMed ID: 24384091
[TBL] [Abstract][Full Text] [Related]
6. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway.
Liu X; Wang F; Du W; Yang X
Arch Esp Urol; 2023 Jun; 76(4):290-297. PubMed ID: 37455528
[TBL] [Abstract][Full Text] [Related]
7. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
8. Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling.
Zi X; Lusch A; Blair CA; Okhunov Z; Yokoyama NN; Liu S; Baker M; Huynh V; Landman J
Oncotarget; 2016 Aug; 7(33):53277-53288. PubMed ID: 27409168
[TBL] [Abstract][Full Text] [Related]
9. [Beta-catenin and its mRNA in renal cell carcinoma].
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):37-9. PubMed ID: 11831984
[TBL] [Abstract][Full Text] [Related]
10. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
11. Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin.
Kim H; Rodriguez-Navas C; Kollipara RK; Kapur P; Pedrosa I; Brugarolas J; Kittler R; Ye J
Cell Rep; 2015 Oct; 13(3):495-503. PubMed ID: 26456834
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Tabatabai ZL; Hinoda Y; Dahiya R
Int J Cancer; 2011 Nov; 129(10):2360-9. PubMed ID: 21207373
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
15. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
[TBL] [Abstract][Full Text] [Related]
16. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
Wu K; Xu L; Zhang L; Lin Z; Hou J
Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
[TBL] [Abstract][Full Text] [Related]
17. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract][Full Text] [Related]
18. LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration.
Lu L; Lei Y; Li Y; Wang L
Aging (Albany NY); 2024 Jan; 16(2):1484-1495. PubMed ID: 38226972
[TBL] [Abstract][Full Text] [Related]
19. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
[TBL] [Abstract][Full Text] [Related]
20. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin.
Choi H; Chun YS; Kim TY; Park JW
Cancer Res; 2010 Dec; 70(24):10101-11. PubMed ID: 21159632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
